{
  "id": 10478290,
  "title": "Kodiak's stock soars as it clinches crucial Phase 3 win for Eylea competitor",
  "url": "https://urgent.news/2026/09/28/kodiaks-stock-soars-as-it-clinches-crucial-phase-3-win-for-eylea",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T15:19:38.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/kodiaks-stock-soars-as-it-clinches-crucial-phase-3-win-for-eylea-competitor/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kodiak Sciences appears to have an Eylea successor on its hands. The Silicon Valley biotech said its experimental drug Zenkuda performed as well as Eylea in a progressive eye disease known as wet age-related macular ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}